✦ LIBER ✦

Overview of the Potency of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®)

✍ Scribed by Barry A. Schlech; Eduardo Alfonso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future of Ophthalmic Anti-infective Ther

✍ Barry A. Schlech; Joseph Blondeau 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Clinical Safety of Moxifloxacin Ophthalm

✍ Lewis H. Silver; Adrienne M. Woodside; Dawnelle B. Montgomery 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

In Vitro and In Vivo Potency of Moxiflox

✍ David W. Stroman; Joseph J. Dajcs; Gale A. Cupp; Barry A. Schlech 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Aqueous penetration of moxifloxacin 0.5%

✍ Junko Yoshida; Alisa Kim; Kimberly A. Pratzer; Walter J. Stark 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Safety of prophylactic intracameral moxi

✍ Cesar Ramon G. Espiritu; Victor L. Caparas; Joanne G. Bolinao 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Efficacy and Safety of Besifloxacin Opht

✍ Marguerite B. McDonald; Eugene E. Protzko; Lynne S. Brunner; Timothy W. Morris; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 923 KB